These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8136540)

  • 1. Calcitriol (1 alpha,25-dihydroxyvitamin D3) ointment in psoriasis, a safety tolerance and efficacy multicentre study.
    Wishart JM
    Dermatology; 1994; 188(2):135-9. PubMed ID: 8136540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
    Langner A; Ashton P; Van De Kerkhof PC; Verjans H
    Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children.
    Saggese G; Federico G; Battini R
    Eur J Pediatr; 1993 May; 152(5):389-92. PubMed ID: 8319701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis.
    Pèrez A; Chen TC; Turner A; Raab R; Bhawan J; Poche P; Holick MF
    Br J Dermatol; 1996 Feb; 134(2):238-46. PubMed ID: 8746336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis.
    Barker JN; Berth-Jones J; Groves R; Omerod AD; Rizova E; Griffiths CE
    J Dermatolog Treat; 2003 Jan; 14(1):14-21. PubMed ID: 12745850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
    Guzzo C; Lazarus G; Goffe BS; Katz HI; Lowe NJ; Pincus SH
    J Am Acad Dermatol; 1996 Mar; 34(3):429-33. PubMed ID: 8609254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral calcium tolerance test in extensive psoriasis treated with topical calcipotriol.
    Gumowski-Sunek D; Rizzoli R; Saurat JH
    Dermatology; 1995; 190(1):43-7. PubMed ID: 7894096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study.
    Carboni I; de Felice C; Bergamin A; Chimenti S
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():11-3. PubMed ID: 16274406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.
    van de Kerkhof PC; Berth-Jones J; Griffiths CE; Harrison PV; Hönigsmann H; Marks R; Roelandts R; Schöpf E; Trompke C
    Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
    Van de Kerkhof PC; Green C; Hamberg KJ; Hutchinson PE; Jensen JK; Kidson P; Kragballe K; Larsen FG; Munro CS; Tillman DM
    Dermatology; 2002; 204(3):214-21. PubMed ID: 12037450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis.
    Bourke JF; Mumford R; Whittaker P; Iqbal SJ; Le Van LW; Trevellyan A; Hutchinson PE
    J Am Acad Dermatol; 1997 Dec; 37(6):929-34. PubMed ID: 9418759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M; Mrowietz U; Koenig M; Simon JC
    Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety of topical calcitriol 3 microg g(-1) ointment.
    Gerritsen MJ; Van De Kerkhof PC; Langner A
    Br J Dermatol; 2001 Apr; 144 Suppl 58():17-9. PubMed ID: 11501508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903).
    Kragballe K
    Arch Dermatol; 1989 Dec; 125(12):1647-52. PubMed ID: 2531570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study.
    Durakovic C; Malabanan A; Holick MF
    Br J Dermatol; 2001 Mar; 144(3):500-6. PubMed ID: 11260006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitriol ointment: optimizing psoriasis therapy.
    Gold LF
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topically applied low-dose calcitriol has no calciotropic effect in patients with stable plaque psoriasis.
    Sips AJ; Netelenbos JC; Barto R; Verburgh CA; Nieboer C; van der Vijgh WJ
    J Am Acad Dermatol; 1994 Jun; 30(6):966-9. PubMed ID: 8188888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.